Copyright
©The Author(s) 2018.
World J Gastrointest Endosc. Dec 16, 2018; 10(12): 400-421
Published online Dec 16, 2018. doi: 10.4253/wjge.v10.i12.400
Published online Dec 16, 2018. doi: 10.4253/wjge.v10.i12.400
Median age; range | Patient total | Study design | VCE Model | DBE Model | Preparation | Interval CE × DBE | No. of patients with diagnoses of SBB by CE/total CE performed | No. of patients with diagnoses of SBB by DBE/total DBE performed | |
Fujimoto et al[28], 2007 | 64 (38-93) | 45 M: 25 F: 20 | Prospective study | Pillcam (Given Imaging, Yoqneam, Israel). | EN-450P5 DBE diagnostic model and/or the EN-450T5 | CE: 12 h fast + 1 L sodium sulfate/sodium bicarbonate DBE: 72 h after CE in 36 pct | 72 h | 18/45 Angiodysplasia: 6 Varices: 2 jejunal | 18/36 |
Hadithi et al[4], 2006 | 63.2 (19-86) | 35 M:22 F: 13 | Prospective blinded study | Given M2A, Given Imaging Ltd., Yoqneam, Israel | Fuji Photo Optical Incorporated Company Fujinon Inc., Japan | CE: fast overnight after the ingestion of 1 L of sodium sulfate/sodium bicarbonate solution DBE: fast overnight after ingestion of 1 L clean prep. for the antegrade approach and bowel cleansing as for colonoscopy (4 L Klean prep) | 7 to 14 d | 21/35 AVM: 19 Fresh blood and clots: 5 | 28/35 AVM: 16 Fresh blood and clots: 2 |
Hermans et al[11], 2017 | 69 (18-91) | 146 M: 91 F: 55 | Retrospective observational study. | Olympus VC (Olympus EndoCapsule; Tokyo, Japan) and Pillcam VC (Covidien plc, Dublin, Ireland) | Fujinon Double-Balloon Enteroscopy System (Fujinon GMBH, Germany), EN-450T5 | CE: 2 L PEG in a single or split dose DBE: 1 L PEG divided into two doses to be used twice | 111 (1–1091) days | 105/134 Angiodysplasias: 70 active bleedings without visible focus : 35 | 93/146 Angiodysplasias: 19 |
Holleran et al[37], 2013 | 54 (16-90) | 246 M: 130 F: 116 | Retrospective comparative study | SB1 or SB2 pillcam (Given imaging, Yokneam, Israel) | Fujinon double-balloon enteroscope (EN-450P5/20, Fujinon, Inc., Saitama, Japan) | CE: No preparation was required other than an overnight fast. Anterograde DBE: overnight fast Retrograde DBE: PEG the day prior | NR* | 40/46 Angiodysplasia: 10 Active bleeding: 3 | 116/246 Angiodysplasias: 44 |
Kaffes et al[34], 2007 | 62 ± 18 | 60 | Prospective cohort study | M2A; Given Imaging Ltd, Yoqneam, Israel) | Fujinon | CE, DBE: fasting period of 8 h before the oral procedure and a bowel preparation with a sodium (Picoprep; Pharmatel, Thornleigh, Australia) | NR* | 45/60 Angiectasia:28 Red spots: 9 Blood: 8 | 45/60 Angioectasia: 21 Red spots: 9 Blood: 8 |
Kalra, A et al[16], 2015 | 66.6 ± 13.2 | 116 M:65 F: 51 | Retrospective review | Medtronic, Duluth, GA, the United States | Fujifilm Medical System, Stanford, CT, the United States | Retrograde DBE: bowel preparation the night before the procedure. | 1 yr | /69 | 29/69 AVM: 29 |
Kamalaporn et al[30], 2008 | 64.1 (34-83) | 195 M: 26 F:25 | Retrospective review | Given M2A CE system (Given Imaging Ltd, Israel) | Fujinon DBE system (Fuji Photo Optical Incorporated Company, Fujinon Inc., Japan) | CE: 2 to 4 L PEG and fasted overnight, at least 8 h before the procedure DBE: 4 L PEG and fasted overnight | 139 (40 to 335) d | 181/202 studies Angiodysplasia: 33 Bleeding: 22 | 56/56 Angiodysplasia: 36 Bleeding: 9 |
Kameda et al[27], 2008 | 62.4 (27-84) | 32 M: 13 F: 19 | Prospective single-blind trial | Pill Cam capsule (M2A, Given Imaging, Yoqneam, Israel) | DBE system (FujinonToshiba ES System, Saitama, Japan) | CE: fasting after midnight on the evening before the examination (minimum 8 h) DBE: overnight fasting and ingestion of 1 l of electrolyte lavage preparation (Niflec, Ajinomoto Pharma, Tokyo, Japan) in the morning. | 1-7 d | 29/32 Angiodysplasia: 8 bleeding: 6 | 21/32 Angiodysplasia: 7 bleeding: 6 |
Li et al[35], 2010 | 190 | Prospective study | M2A, Given Imaging, Ltd. (Yoqneam, Israel) | Fujinon EN-450P5/ 20 and EN-450P5/28 (Fujinon Inc., Saitama, Japan) | CE: 1 L of PEG electrolyte 12 h before the procedure Anterograde DBE: fasted for 8 h. Retrograde DBE: PEG electrolytes preparation 4 h before the examination | 5.8 d (1-18) | 165/190 AVM: 7 Fresh blood or clots: 8 | 34/51 AVM: 9 Bleeding: 0 Angioma: 4 | |
Lin et al[40], 2007 | 63.5 ± 22.7 (11-87) | 10 M:3 F:7 | Prospective study | Pill Cam SB capsule (Given Imaging, Yoqneam, Israel) | DBE: EN- 450P5 and the EN-450T5 | CE: fast overnight for 8-12 h Anterograde DBE: fasting for 6-8 h Retrograde DBE: bowel cleansing as in a colonoscopy. | 7 d | 9/10 Angiodysplasias: 3 Bleeding: 3 | 8/10 Angiodysplasias: 3 Varices: 1 Dieulafoy’s lesion: 1 |
Maeda et al[32], 2010 | 70 (30-92) | 89 M: 48 F: 41 | Retrospective analysis | PilCam SB® (SB1, SB2, or SB3) (Covidien, Irvine, CA, the United States). | (EN-450 T5/W or EN-580 T, Fujinon Inc., Saitama, Japan) | NR* | 24 h | 58/89 Angioectasia: 8 AVM : 3 Dieulafoy lesion: 9 Varices: 2 | 29/37 Angioectasia:8 AVM: 3 Dieulafoy lesion:6 Varice: 1 |
Marmo R et al[23], 2008 | 61.6 ± 16.2 | 193 M: 119 F: 74 | Prospective study | Pillcam SB | Fujinon Double-Balloon Enteroscopy System | Anterograde DBE: fasting period of 8 h Retrograde DBE: 4 L PEG-based preparation | 2 wk | 175/193 Vascular lesions: 74 Blood or clot: 34 | 132/193 Vascular lesions: 72 |
Tian Min et al[39], 2013 | 55.4 (23-78) | 62 M: 34 F:28 | Prospective study | Pill Cam SB capsule | EN-450P5 and the EN-450T5 (Fujinon) | CE: 2 L to 4 L PEG and fasted overnight Anterograde DBE: fasting for 6-8 h before the procedure. Retrograde DBE: bowel cleansing as in a colonoscopy. | 15 (4-60) d | 44/62 Angiodysplasia: 26 Bleeding: 26 | 48/62 Angiodysplasia: 27 Bleeding: 30 |
Nakamura et al[29], 2006 | 58.5 (25 ± 85) | 32 M: 21 F: 11 | Prospective and blinded | M2A, Given Imaging, | Fuji EN−450 T5/20 | CE: fluid diet for 12 h and observed a fasting period starting at midnight Anterograde DBE: fasted for 12 h Retrograde DBE: clear liquid diet on the day before the examination and PEG electrolyte lavage solution on the morning of the examination | 48 h | 19/32 Angiodysplasias: 4 Red spots: 2 | 12/28 Angiodysplasias: 2 Red spots: 2 |
Rahmi et al[33], 2013 | 67 ± 11 | 383 M: 114 F: 269 | Prospective, multicenter study | PillCam SB device | EN-450P5 and EN-450T5; Fujinon | CE: residue-free diet 2 d before VCE ingestion; 2 L PEG solution the night before the examination; patients then fasted overnight Anterograde DBE: No bowel preparation Retrograde DBE: 4 L of a PEG solution was given the day before the procedure | 4.1 ± 6.3 mo | 266/383 Angiodysplasia: 266 | 205/266 Angiodysplasia: 190 |
Chu et al[17], 2016 | 51.1 ± 17.1 | 121 M: 60 F: 61 | Study Cohorts | OMOM capsule endoscopic device (Jinshan Science and Technology Group Co., Ltd, Chongqing, China) | Fujinon EN-450P5/20 | CE: 2 L polyethylene glycol-based electrolyte solution 12 h prior to the test, followed by an overnight fast for bowel preparation fast Retrograde DBE: bowel preparation used for CE procedure the day before the examination | 1 wk | 115/121 Angiodysplasia: 86% Active bleeding: 6 | 29/46 Angiodysplasia: 9 |
Zhang et al[15], 2015 | 47.19 (16-78) | 88 M: 64 F: 24 | Prospective study | Pill Cam SB | Fuji DBE system | CE: 3 liters of PEG (2 liters at 10:00 pm the night before the procedure, and 1 L with the simethicone at 4:00 am on the morning of the procedure) Anterograde DBE: fast for 6-8 h Retrograde DBE: 2 L of PEG | NR | 53/88 MAV: 14 Hemangioma: 0 Diverticulum with a Bleeding: 1 | 52/88 MAV: 10 Hemangioma: 3 Diverticulum with a Bleeding: 7 |
- Citation: Brito HP, Ribeiro IB, de Moura DTH, Bernardo WM, Chaves DM, Kuga R, Maahs ED, Ishida RK, de Moura ETH, de Moura EGH. Video capsule endoscopy vs double-balloon enteroscopy in the diagnosis of small bowel bleeding: A systematic review and meta-analysis. World J Gastrointest Endosc 2018; 10(12): 400-421
- URL: https://www.wjgnet.com/1948-5190/full/v10/i12/400.htm
- DOI: https://dx.doi.org/10.4253/wjge.v10.i12.400